Globus Medical Valuation Multiples

Globus Medical Overview

About Globus Medical

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.

Founded

2003

HQ

Employees

6.0K

Website

globusmedical.com

Sectors

Medical DevicesDeepTechHealthTech

Financials (LTM)

Revenue: $3B

EBITDA: $953M

EV

$12B

Valuation Multiples

Multiples.vc

Start free trial

Globus Medical Financials

Globus Medical reported last 12-month revenue of $3B and EBITDA of $953M.

In the same LTM period, Globus Medical generated $2B in gross profit, $953M in EBITDA, and $563M in net income.

Globus Medical P&L

In the most recent fiscal year, Globus Medical reported revenue of $3B and EBITDA of $920M.

Globus Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX

Globus Medical Stock Performance

Globus Medical has current market cap of $13B, and enterprise value of $12B.

Globus Medical's stock price is $93.80.

Globus Medical Valuation Multiples

Globus Medical trades at 4.1x EV/Revenue multiple, and 12.9x EV/EBITDA.

Globus Medical Financial Valuation Multiples

As of April 5, 2026, Globus Medical has market cap of $13B and EV of $12B.

Equity research analysts estimate Globus Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Globus Medical has a P/E ratio of 22.3x.

Globus Medical Margins & Growth Rates

Globus Medical's revenue in the last 12 month grew by 8%.

Globus Medical's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.2M for the same period.

Globus Medical's rule of 40 is 42% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Globus Medical's rule of X is 55% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Globus Medical Public Comps

See public comps and valuation multiples for other Medical Devices comps.

Globus Medical M&A Activity

Globus Medical acquired XXX companies to date.

Last acquisition by Globus Medical was on XXXXXXXX, XXXXX. Globus Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Globus Medical Investment Activity

Globus Medical invested in XXX companies to date.

Globus Medical made its latest investment on XXXXXXXX, XXXXX. Globus Medical invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).